Crinetics Pharmaceuticals
CRNX
CRNX
239 hedge funds and large institutions have $5.19B invested in Crinetics Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 91 increasing their positions, 77 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3.23% more ownership
Funds ownership: 114.37% → 117.6% (+3.2%)
1% less call options, than puts
Call options by funds: $27.3M | Put options by funds: $27.6M
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
Holders
239
Holding in Top 10
5
Calls
$27.3M
Puts
$27.6M
Top Buyers
| 1 | +$60.9M | |
| 2 | +$51.8M | |
| 3 | +$27.9M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$25.9M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$22.3M |
Top Sellers
| 1 | -$34M | |
| 2 | -$31.2M | |
| 3 | -$28M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$15.3M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
-$15.1M |
